OPENEDGES Technology (394280) 2026 stock outlook. A qualitative deep dive into its on-chip memory controller, NPU and interconnect semiconductor IP licensing-plus-royalty model, comparison with ARM and Rambus, on-device AI demand leverage, and the unresolved path to sustained profitability.
PSK Holdings (031980) 2026 stock outlook. A Korean holding company whose value rests on its controlling stake in PSK Inc (319660), the dry-strip and photoresist-removal front-end equipment maker, leveraged to the memory capex cycle and HBM etch demand but weighed down by a persistent parent-subsidiary holding discount, analyzed qualitatively for US investors.
JW Holdings (096760) 2026 stock outlook. A deep qualitative look at Korea's IV-fluid oligopoly moat, JW Life Science and JW Bioscience subsidiary leverage, the gout and oncology pipeline, holding-company NAV discount, and drug-pricing risk for the JW Pharmaceutical group.
KBI Metal (024120) stock outlook for 2026. A close look at its wire, magnet-wire (winding), and auto-parts businesses, why the copper conversion spread matters more than the copper price, its leverage to grid and EV-motor demand, and what would trigger a re-rating of this low-PBR Korean materials stock.
Daemyung Energy (389260) 2026 stock outlook. A qualitative deep dive into its wind and solar EPC track record, recurring O&M revenue, owned generation-asset cash flow, RPS and REC policy sensitivity, interest-rate exposure, and project-pipeline execution risk for the KOSDAQ developer.
Chong Kun Dang Holdings (KRX: 001630) 2026 stock outlook. A qualitative deep dive into the pharmaceutical holding-company NAV discount, the earnings leverage from subsidiaries Chong Kun Dang, Kyongbo Pharm, CKD Bio and CKD Health, how the holdco differs from operating company Chong Kun Dang (185750), plus dividend appeal and owner-governance risk.
Interflex (051370) 2026 stock outlook. A qualitative deep dive into its flexible printed circuit board (FPCB) supply to Samsung Display OLED and Samsung Electronics smartphones, single-customer concentration risk, Chinese low-cost competition, OLED and automotive expansion leverage, plus US-investor tax and FX considerations.
KH Vatec (060720) 2026 stock outlook. A deep qualitative look at its foldable-smartphone hinge and metal-case franchise, the precision-machining moat, single-customer concentration on Samsung, set-launch seasonality, foldable penetration leverage, and the competing hinge-vendor landscape.
Suheung (008490) 2026 stock outlook. A deep qualitative look at its near-monopoly in domestic hard capsules and top-three global position, the health-supplement contract-manufacturing (ODM) growth lever, and the gelatin, currency, and demand-cycle risks facing this KOSDAQ materials name.
A qualitative 2026 outlook on JNTC (KOSDAQ 204270), the Korean maker of 3D tempered cover glass and connectors: its glass-forming moat, deep Samsung supply-chain exposure, the automotive-connector expansion, and sensitivity to smartphone demand, the won-dollar rate, and set-maker cycles.
A qualitative 2026 outlook on Kangnam Jevisco (000860), the Korean mid-cap paint maker behind the Jebipyo brand. We cover its exposure to construction, shipbuilding, and auto cycles, its shift toward eco-friendly high-value coatings, its low-PBR asset-value case, and thin trading liquidity.
Kolmar Holdings (KRX 024720, formerly Kolmar Holdings Korea) 2026 stock outlook. A qualitative look at the pure holding company controlling Kolmar Korea's cosmetics ODM export boom and HK inno.N's K-CAB pharma pipeline, the persistent Korean holding-company discount, and what US and global investors should weigh before buying this KRX parent ticker.
SK Discovery (006120) stock outlook for 2026. A qualitative deep dive into the Chey Chang-won branch of SK Group, its control over SK Chemicals, SK Gas, and SK Bioscience, the vaccine-to-hydrogen value chain, PFIC risk for US holders, and why the holding company discount runs so deep here.
Kolon (002020) stock outlook 2026: a qualitative read on the holding company behind Kolon Industries' hydrogen materials and Kolon Global's construction business, weighing holding discount, cycle risk, and dividend income.
BGF (027410) stock outlook for 2026. A deep, qualitative look at the pure holding company controlling BGF Retail (282330), operator of Korea's CU convenience store chain, covering holding-company discount mechanics, convenience-store saturation, and the BGF Eco Materials optionality.
Daesang Holdings (084690) stock outlook 2026. A qualitative look at the pure holding company controlling Daesang Corp's Chungjungwon and Jongga food brands — dividend and royalty income, NAV versus market cap, and the lysine/starch-sugar cycle risk hidden inside a food conglomerate.
Kyungnong (KRX: 002100) 2026 stock analysis: Korea's top-tier crop protection maker paired with fertilizer subsidiary Jobi, seasonal earnings tied to the farming calendar, climate-driven demand shifts, an aging rural workforce pushing drone application, and the eco-friendly transition risk global investors should track.
Dongil Industries (004890) stock outlook for 2026 covers its position in the POSCO steel supply chain, why the stock persistently trades at a fraction of book value, its exposure to construction equipment demand cycles, and dividend reliability.
EcoPro HN (KOSDAQ: 383310) stock outlook for 2026, covering its emissions-control equipment and semiconductor cleanroom chemical filter businesses, its role as the EcoPro Group's steady cash generator, capex-cycle risk, and how US investors can realistically access this KOSDAQ small-cap.
Sebang (004360) 2026 stock outlook. A deep look at its integrated-logistics model — container inland trucking, port stevedoring, heavy-lift cargo — how it differs from Sebang Global Battery (004490), port throughput cyclicality, 3PL moat, asset-play valuation, and the case for a US investor.
Actoz Soft (052790) 2026 stock outlook. A qualitative deep dive into Legend of Mir (热血传奇) IP royalty cash flow, Shanda/Shengqu Chinese control structure, the long-running Wemade royalty litigation, new-title drought risk, and the IP licensing business model.
Huons Global (084110) stock outlook for 2026. A deep qualitative look at this Korean pharma holding company behind Huons and Humedix: eye-drop cash cow, aesthetics and HA fillers, botulinum toxin exports, China and Brazil regulatory catalysts, dividend appeal, and the persistent holding-company discount.
Kyungbang (000050) 2026 stock outlook. A deep qualitative look at the decline of its 1919 textile legacy, the rental and retail income from the Yeongdeungpo Times Square mall, real-estate asset revaluation, the persistent NAV discount, and retail-tenant cycle risk.
Youngone Holdings (009970) stock outlook for 2026. A deep qualitative look at the holding-company structure over Youngone Corporation (111770), outdoor OEM/ODM manufacturing for brands like The North Face, Bangladesh production, Scott bicycles, the holding discount, customer concentration, and order-cycle risk.